234 results on '"R. Broom"'
Search Results
2. Establishment of clinical exercise physiology as a regulated healthcare profession in the UK: a progress report
- Author
-
Gordon McGregor, Helen Jones, Daniel J Green, Dawn A Skelton, John P Buckley, Andrew Scott, Keith George, Sandy Jack, Gemma Miller, Greg P Whyte, Anna Campbell, Anthony Crozier, Keith Tolfrey, David R Broom, Joanna Rycroft, Christopher David Askew, Steffan Birkett, Lizanne Steenkamp, and Jude Savage
- Subjects
Medicine (General) ,R5-920 - Abstract
In 2021, a ‘call to action’ was published to highlight the need for professional regulation of clinical exercise physiologists to be established within UK healthcare systems to ensure patient safety and align training and regulation with other health professions. This manuscript provides a progress report on the actions that Clinical Exercise Physiology UK (CEP-UK) has undertaken over the past 4 years, during which time clinical exercise physiologists have implemented regulation and gained formal recognition as healthcare professionals in the UK. An overview of the consultation process involved in creating a regulated health profession, notably the development of policies and procedures for both individual registration and institutional master’s degree (MSc) accreditation is outlined. Additionally, the process for developing an industry-recognised scope of practice, a university MSc-level curriculum framework, the Academy for Healthcare Science Practitioner standards of proficiency and Continuing Professional Development opportunities is included. We outline the significant activities and milestones undertaken by CEP-UK and provide insight and clarity for other health professionals to understand the training and registration process for a clinical exercise physiologist in the UK. Finally, we include short, medium and long-term objectives for the future advocacy development of this workforce in the UK.
- Published
- 2024
- Full Text
- View/download PDF
3. Smart technology for healthcare: Exploring the antecedents of adoption intention of healthcare wearable technology
- Author
-
Ka Yin Chau, Michael Huen Sum Lam, Man Lai Cheung, Ejoe Kar Ho Tso, Stuart W. Flint, David R. Broom, Gary Tse, and Ka Yiu Lee
- Subjects
Medicine ,Mental healing ,RZ400-408 - Abstract
Technological advancement and personalized health information has led to an increase in people using and responding to wearable technology in the last decade. These changes are often perceived to be beneficial, providing greater information and insights about health for users, organizations and healthcare and government. However, to date, understanding the antecedents of its adoption is limited. Seeking to address this gap, this cross-sectional study examined what factors influence users’ adoption intention of healthcare wearable technology. We used self-administrated online survey to explore adoption intentions of healthcare wearable devices in 171 adults residing in Hong Kong. We analyzed the data by Partial least squares – structural equation modelling (PLS-SEM). The results reveal that perceived convenience and perceived irreplaceability are key predictors of perceived usefulness, which in turn strengthens users’ adoption intention. Additionally, the results also reveal that health belief is one of the key predictors of adoption intention. This paper contributes to the extant literature by providing understanding of how to strengthen users’ intention to adopt healthcare wearable technology. This includes the strengthening of perceived convenience and perceived irreplaceability to enhance the perceived usefulness, incorporating the extensive communication in the area of healthcare messages, which is useful in strengthening consumers’ adoption intention in healthcare wearable technology.
- Published
- 2019
- Full Text
- View/download PDF
4. Safety of home-based exercise for people with intermittent claudication: A systematic review
- Author
-
Alexander Waddell, Sally Seed, David R Broom, Gordon McGregor, Stefan T Birkett, and Amy E Harwood
- Subjects
Heart Diseases ,Humans ,Pain ,Walking ,Intermittent Claudication ,Cardiology and Cardiovascular Medicine ,C600 ,R1 ,Exercise Therapy - Abstract
Intermittent claudication (IC) is a classic symptom of peripheral artery disease, with first line treatment being supervised exercise therapy (SET). Despite this, SET is frequently underutilised, and adherence is often poor. An alternative option are home-based exercise programmes (HBEP). Although HBEPs are well tolerated, to the authors’ knowledge, no research has assessed their safety. The aim of this review was to assess the safety of HBEPs in people living with IC. We performed an electronic search of the MEDLINE, CINAHL, and Cochrane Library databases. The main parameter of interest was complication rate, calculated as the number of related adverse events per patient-hours. Subanalysis was undertaken to determine differences in safety for studies that did and did not include pre-exercise cardiac screening, and for studies with exercise at low, moderate, and high levels of claudication pain. Our search strategy identified 8693 results, of which 27 studies were included for full review. Studies included 1642 participants completing 147,810 patient-hours of home-based exercise. Four related adverse events were reported, three of which were cardiac in origin, giving an all-cause complication rate of one event per 36,953 patient-hours. Three of these events occurred following exercise to high levels of claudication pain, and one occurred with pain-free exercise. One event occured in a study without cardiac screening. Based on the low number of related adverse events, HBEPs appear to be a safe method of exercise prescription for people with IC. Our results strengthen the rationale for providing alternative exercise options for this population. PROSPERO Registration No.: CRD42021254581
- Published
- 2021
5. Influence of water-based exercise on energy intake, appetite, and appetite-related hormones in adults: A systematic review and meta-analysis
- Author
-
Marie J. Grigg, C. Douglas Thake, Judith E. Allgrove, James A. King, Alice E. Thackray, David J. Stensel, Alun Owen, and David R. Broom
- Subjects
Nutrition and Dietetics ,General Psychology - Abstract
Single bouts of land-based exercise suppress appetite and do not typically alter energy intake in the short-term, whereas it has been suggested that water-based exercise may evoke orexigenic effects. The primary aim was to systematically review the available literature investigating the influence of water-based exercise on energy intake in adults (PROSPERO ID number CRD42022314349). PubMed, Medline, Sport-Discus, Academic Search Complete, CINAHL and Public Health Database were searched for peer-reviewed articles published in English from 1900 to May 2022. Included studies implemented a water-based exercise intervention versus a control or comparator. Risk of bias was assessed using the revised Cochrane 'Risk of bias tool for randomised trials' (RoB 2.0). We identified eight acute (same day) exercise studies which met the inclusion criteria. Meta-analysis was performed using a fixed effects generic inverse variance method on energy intake (8 studies (water versus control), 5 studies (water versus land) and 2 studies (water at two different temperatures)). Appetite and appetite-related hormones are also examined but high heterogeneity did not allow a meta-analysis of these outcome measures. We identified one chronic exercise training study which met the inclusion criteria with findings discussed narratively. Meta-analysis revealed that a single bout of exercise in water increased ad-libitum energy intake compared to a non-exercise control (mean difference [95% CI]: 330 [118, 542] kJ, P = 0.002). No difference in ad libitum energy intake was identified between water and land-based exercise (78 [-176, 334] kJ, P = 0.55). Exercising in cold water (18-20 °C) increased energy intake to a greater extent than neutral water (27-33 °C) temperature (719 [222, 1215] kJ; P 0.005). The one eligible 12-week study did not assess whether water-based exercise influenced energy intake but did find that cycling and swimming did not alter fasting plasma concentrations of total ghrelin, insulin, leptin or total PYY but contributed to body mass loss 87.3 (5.2) to 85.9 (5.0) kg and 88.9 (4.9) to 86.4 (4.5) kg (P 0.05) respectively. To conclude, if body mass management is a person's primary focus, they should be mindful of the tendency to eat more in the hours after a water-based exercise session, particularly when the water temperature is cold (18-20 °C).
- Published
- 2022
6. 'It is Easy to do Nothing and Easy to Sit Down': Perceptions of Physical Activity and Sedentary Behaviors During Pre-retirement
- Author
-
Karl Spiteri, David R. Broom, Kate Grafton, Bob Laventure, and John Xerri de Caro
- Subjects
Retirement ,B900 Others in Subjects allied to Medicine ,Humans ,Sedentary Behavior ,Geriatrics and Gerontology ,Exercise ,Life Style ,Gerontology - Abstract
This study explored the insights of old age pre-retirement employees towards physical activity and sedentary behavior. A quota sampling of 20 participants from within the Civil Service in Malta were invited to an interview. Participants who were included met the statutory requirement for retirement within the subsequent 6 months to 1 year. Semi-structured interviews were conducted using a narrative approach. Structural narrative analysis and reflective thematic analysis were used. The story structure highlighted the significance of the individual experiences on the perceptions towards future physical activity during retirement. Two themes were identified using the thematic analysis, influencers, and perceptions. Triangulation identified that sedentary behavior was not part of the narration. The transition from work to retirement is a unique and personal experience and therefore when promoting an active lifestyle, the individual experience and past behaviors must be actively considered.
- Published
- 2022
7. Physical Activity and Exercise: Challenging Misconceptions and Considerations for People with Obesity
- Author
-
David R. Broom, Matthew Haines, and Matthew S. Capehorn
- Published
- 2022
8. Immature ALS-associated mutant superoxide dismutases form variable aggregate structures through distinct oligomerization processes
- Author
-
Harmeen K, Deol, Helen R, Broom, Bruna, Siebeneichler, Brenda, Lee, Zoya, Leonenko, and Elizabeth M, Meiering
- Subjects
Protein Folding ,Superoxide Dismutase-1 ,Superoxide Dismutase ,Amyotrophic Lateral Sclerosis ,Mutation ,Organic Chemistry ,Biophysics ,Humans ,Disulfides ,Biochemistry - Abstract
Protein misfolding and aggregation are hallmarks of many diseases, including amyotrophic lateral sclerosis (ALS). In familial ALS, aberrant self-association of mutant Cu,Zn-superoxide dismutase (SOD1) is implicated as a key contributor to disease. Mutations have the largest impacts on the stability of the most immature form of SOD1, the unmetallated, disulfide-reduced monomer (apoSH SOD1). Here we demonstrate that, despite the marginal stability of apoSH SOD1, aggregation is little correlated with the degree of protein unfolding, and multiple modes of aggregation occur, depending on the mutation and solution conditions. Light scattering and atomic force microscopy reveal two distinct mutant SOD1 behaviours: high aggregator mutants form abundant small assemblies, while low aggregator mutants form fewer, more fibre-like aggregates. Attenuated total reflectance-Fourier transform infrared spectroscopy and Thioflavin T binding show the aggregates maintain native-like anti-parallel beta structure. These results provide new evidence that ALS-associated mutations promote the aggregation of apoSH SOD1 through multiple pathways, with broad implications for understanding mechanisms of protein self-association in disease and biotechnology.
- Published
- 2022
9. Safety outcomes from monarchE: phase 3 study of abemaciclib combined with endocrine therapy (ET) for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer (EBC)
- Author
-
Mattea Reinisch, T Yamashita, R. Broom, Ashwin Shahir, M. Gumus, Annamaria Zimmermann, Hope S. Rugo, B. San Antonio, Flora Zagouri, Chuan-gui Song, and Joyce O'Shaughnessy
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Node (networking) ,medicine.medical_treatment ,Endocrine therapy ,Phases of clinical research ,chemistry.chemical_compound ,chemistry ,Internal medicine ,medicine ,business ,Abemaciclib ,Adjuvant ,Early breast cancer - Published
- 2021
10. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
- Author
-
N. Harbeck, P. Rastogi, M. Martin, S.M. Tolaney, Z.M. Shao, P.A. Fasching, C.S. Huang, G.G. Jaliffe, A. Tryakin, M.P. Goetz, H.S. Rugo, E. Senkus, L. Testa, M. Andersson, K. Tamura, L. Del Mastro, G.G. Steger, H. Kreipe, R. Hegg, J. Sohn, V. Guarneri, J. Cortés, E. Hamilton, V. André, R. Wei, S. Barriga, S. Sherwood, T. Forrester, M. Munoz, A. Shahir, B. San Antonio, S.C. Nabinger, M. Toi, S.R.D. Johnston, J. O’Shaughnessy, M.M. Jimenez, S. Johnston, F. Boyle, P. Neven, Z. Jiang, M. Campone, J. Huober, C. Shimizu, I. Cicin, A. Wardley, G.G. Abuin, J. Zarba, E. Lim, P. Sant, N. Liao, B. Christiansen, N. Eigeliene, J. Martin-Babau, J. Ettl, D. Mavroudis, J. Chiu, K. Boer, R. Nagarkar, S. Paluch-Shimon, L. Moscetti, Y. Sagara, S.-B. Kim, M.M. Maciel, V. Tjan-Heijnen, R. Broom, A. Lacko, M. Schenker, N. Volkov, Y. Sim Yap, M. Coccia-Portugal, J. Ángel García Sáenz, A. Andersson, T.-Y. Chao, E. Gokmen, H. Harputluoglu, O. Berzoy, D. Patt, H. McArthur, H. Chew, P. Chalasani, P. Kaufman, K. Tedesco, S.L. Graff, Institut Català de la Salut, [Harbeck N] Breast Center, Department of OB & GYN and CCC Munich, LMU University Hospital, Munich, Germany. [Rastogi P] University of Pittsburgh/UPMC, NSABP Foundation, Pittsburgh, USA. [Martin M] Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain. [Tolaney SM] Dana-Farber Cancer Institute, Boston, USA. [Shao ZM] Fudan University Shanghai Cancer Center, Shanghai, China. [Fasching PA] University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. [Cortés J] International Breast Cancer Center (IBCC), Madrid & Barcelona. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Oncology ,Receptor, ErbB-2 ,abemaciclib ,adjuvant ,CDK4/6 ,early breast cancer ,Ki-67 ,Aminopyridines ,Antineoplastic Combined Chemotherapy Protocols ,Benzimidazoles ,Chemotherapy, Adjuvant ,Disease-Free Survival ,Female ,Humans ,Ki-67 Antigen ,Neoplasm Recurrence, Local ,Breast Neoplasms ,medicine.medical_treatment ,Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES] ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,chemistry.chemical_compound ,Tratamiento médico ,ErbB-2 ,Clinical endpoint ,Other subheadings::/therapeutic use [Other subheadings] ,Abemaciclib ,education.field_of_study ,neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES] ,biology ,terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Hematology ,Cáncer ,medicine.anatomical_structure ,Local ,Cohort ,Neoplasias de la mama ,Adjuvant ,Receptor ,medicine.medical_specialty ,Axillary lymph nodes ,Mujer ,Population ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,Quimioteràpia combinada ,Internal medicine ,Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,medicine ,Chemotherapy ,education ,business.industry ,Otros calificadores::/uso terapéutico [Otros calificadores] ,Interim analysis ,Neoplasm Recurrence ,chemistry ,Mama - Càncer - Tractament ,biology.protein ,business - Abstract
Abemaciclib; Adjuvant; Early breast cancer Abemaciclib; Adjuvant; Càncer de mama precoç Abemaciclib; Adyuvante; Cáncer de mama precoz Background Adjuvant abemaciclib combined with endocrine therapy (ET) previously demonstrated clinically meaningful improvement in invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS) in hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive, high-risk early breast cancer at the second interim analysis, however follow-up was limited. Here, we present results of the prespecified primary outcome analysis and an additional follow-up analysis. Patients and methods This global, phase III, open-label trial randomized (1 : 1) 5637 patients to adjuvant ET for ≥5 years ± abemaciclib for 2 years. Cohort 1 enrolled patients with ≥4 positive axillary lymph nodes (ALNs), or 1-3 positive ALNs and either grade 3 disease or tumor ≥5 cm. Cohort 2 enrolled patients with 1-3 positive ALNs and centrally determined high Ki-67 index (≥20%). The primary endpoint was IDFS in the intent-to-treat population (cohorts 1 and 2). Secondary endpoints were IDFS in patients with high Ki-67, DRFS, overall survival, and safety. Results At the primary outcome analysis, with 19 months median follow-up time, abemaciclib + ET resulted in a 29% reduction in the risk of developing an IDFS event [hazard ratio (HR) = 0.71, 95% confidence interval (CI) 0.58-0.87; nominal P = 0.0009]. At the additional follow-up analysis, with 27 months median follow-up and 90% of patients off treatment, IDFS (HR = 0.70, 95% CI 0.59-0.82; nominal P < 0.0001) and DRFS (HR = 0.69, 95% CI 0.57-0.83; nominal P < 0.0001) benefit was maintained. The absolute improvements in 3-year IDFS and DRFS rates were 5.4% and 4.2%, respectively. Whereas Ki-67 index was prognostic, abemaciclib benefit was consistent regardless of Ki-67 index. Safety data were consistent with the known abemaciclib risk profile. Conclusion Abemaciclib + ET significantly improved IDFS in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive, high-risk early breast cancer, with an acceptable safety profile. Ki-67 index was prognostic, but abemaciclib benefit was observed regardless of Ki-67 index. Overall, the robust treatment benefit of abemaciclib extended beyond the 2-year treatment period. This work was supported by the sponsor (Eli Lilly and Company) and designed together with the study Executive Committee (no grant number).
- Published
- 2021
11. Exercise and Diet
- Author
-
Matthew M. Schubert and David R. Broom
- Published
- 2020
12. Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer
- Author
-
B. San Antonio, Mattea Reinisch, Hope S. Rugo, Ashwin Shahir, M. Gumus, Toshinari Yamashita, R. Broom, Annamaria Zimmermann, Flora Zagouri, Chuan-gui Song, and Joyce O'Shaughnessy
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Node (networking) ,Endocrine therapy ,Phases of clinical research ,General Medicine ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,chemistry.chemical_compound ,chemistry ,Internal medicine ,medicine ,Surgery ,business ,Adjuvant ,Abemaciclib ,Early breast cancer - Published
- 2021
13. The historical and current context for research into health and physical activity
- Author
-
Stephen R. Bird and David R. Broom
- Subjects
Applied psychology ,Physical activity ,Context (language use) ,Research questions ,Health benefits ,Association (psychology) ,Exercise prescription ,Psychology ,Intervention studies - Abstract
This chapter builds on some of the health issues presented in chapter 1. It commences with a consideration of some of the early beliefs in the benefits of exercise and then progresses to introduce some of the ground-breaking scientific research that initiated the accumulation of hard evidence in support of the association between physical activity and health. It also introduces the rationale for intervention studies that can determine the health benefits from the participation in exercise, and how these have contributed to the current recommendations by health and medical authorities. It then raises some of the current research questions and the need for ongoing research, as we have yet to identify how best to optimise exercise prescription for each individual and to fully understand how such physical activity interacts with other factors that impact upon health, such as nutrition and sedentary behaviour.
- Published
- 2018
14. Concurrent Increases and Decreases in Local Stability and Conformational Heterogeneity in Cu, Zn Superoxide Dismutase Variants Revealed by Temperature-Dependence of Amide Chemical Shifts
- Author
-
Elizabeth M. Meiering, Ashok Sekhar, Colleen M. Doyle, Jessica A.O. Rumfeldt, Helen R. Broom, and Lewis E. Kay
- Subjects
0301 basic medicine ,Protein Conformation ,Mutant ,Population ,SOD1 ,macromolecular substances ,Calorimetry ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Protein Structure, Secondary ,Superoxide dismutase ,03 medical and health sciences ,chemistry.chemical_compound ,Superoxide Dismutase-1 ,Protein structure ,Amide ,education ,education.field_of_study ,Calorimetry, Differential Scanning ,biology ,Protein Stability ,Superoxide Dismutase ,Chemical shift ,Temperature ,Amides ,0104 chemical sciences ,Zinc ,Crystallography ,030104 developmental biology ,chemistry ,biology.protein ,Copper - Abstract
The chemical shifts of backbone amide protons in proteins are sensitive reporters of local structural stability and conformational heterogeneity, which can be determined from their readily measured linear and nonlinear temperature-dependences, respectively. Here we report analyses of amide proton temperature-dependences for native dimeric Cu, Zn superoxide dismutase (holo pWT SOD1) and structurally diverse mutant SOD1s associated with amyotrophic lateral sclerosis (ALS). Holo pWT SOD1 loses structure with temperature first at its periphery and, while having extremely high global stability, nevertheless exhibits extensive conformational heterogeneity, with ∼1 in 5 residues showing evidence for population of low energy alternative states. The holo G93A and E100G ALS mutants have moderately decreased global stability, whereas V148I is slightly stabilized. Comparison of the holo mutants as well as the marginally stable immature monomeric unmetalated and disulfide-reduced (apo(2SH)) pWT with holo pWT shows that changes in the local structural stability of individual amides vary greatly, with average changes corresponding to differences in global protein stability measured by differential scanning calorimetry. Mutants also exhibit altered conformational heterogeneity compared to pWT. Strikingly, substantial increases as well as decreases in local stability and conformational heterogeneity occur, in particular upon maturation and for G93A. Thus, the temperature-dependence of amide shifts for SOD1 variants is a rich source of information on the location and extent of perturbation of structure upon covalent changes and ligand binding. The implications for potential mechanisms of toxic misfolding of SOD1 in disease and for general aspects of protein energetics, including entropy-enthalpy compensation, are discussed.
- Published
- 2016
15. On a Case of Intracranial Disease Treated by Trephining-Death
- Author
-
R, Broom
- Published
- 2018
16. Destabilization of the dimer interface is a common consequence of diverse <scp>ALS</scp> ‐associated mutations in metal free <scp>SOD1</scp>
- Author
-
Jessica A.O. Rumfeldt, Elizabeth M. Meiering, Helen R. Broom, and Kenrick A. Vassall
- Subjects
Models, Molecular ,Protein Folding ,Dimer ,Population ,SOD1 ,Size-exclusion chromatography ,Calorimetry ,Biochemistry ,Protein Structure, Secondary ,Protein–protein interaction ,chemistry.chemical_compound ,Superoxide Dismutase-1 ,Enzyme Stability ,medicine ,Humans ,Amyotrophic lateral sclerosis ,education ,Molecular Biology ,education.field_of_study ,Superoxide Dismutase ,Chemistry ,Amyotrophic Lateral Sclerosis ,Isothermal titration calorimetry ,medicine.disease ,Metal free ,Mutation ,For the Record ,Chromatography, Gel ,Thermodynamics ,Protein Multimerization - Abstract
Neurotoxic misfolding of Cu, Zn‐superoxide dismutase (SOD1) is implicated in causing amyotrophic lateral sclerosis, a devastating and incurable neurodegenerative disease. Disease‐linked mutations in SOD1 have been proposed to promote misfolding and aggregation by decreasing protein stability and increasing the proportion of less folded forms of the protein. Here we report direct measurement of the thermodynamic effects of chemically and structurally diverse mutations on the stability of the dimer interface for metal free (apo) SOD1 using isothermal titration calorimetry and size exclusion chromatography. Remarkably, all mutations studied, even ones distant from the dimer interface, decrease interface stability, and increase the population of monomeric SOD1. We interpret the thermodynamic data to mean that substantial structural perturbations accompany dimer dissociation, resulting in the formation of poorly packed and malleable dissociated monomers. These findings provide key information for understanding the mechanisms and energetics underlying normal maturation of SOD1, as well as toxic SOD1 misfolding pathways associated with disease. Furthermore, accurate prediction of protein–protein association remains very difficult, especially when large structural changes are involved in the process, and our findings provide a quantitative set of data for such cases, to improve modelling of protein association.
- Published
- 2015
17. Many roads lead to Rome? Multiple modes of Cu,Zn superoxide dismutase destabilization, misfolding and aggregation in amyotrophic lateral sclerosis
- Author
-
Elizabeth M. Meiering, Jessica A.O. Rumfeldt, and Helen R. Broom
- Subjects
Protein Folding ,Superoxide Dismutase ,Amyotrophic Lateral Sclerosis ,SOD1 ,Cu-Zn Superoxide Dismutase ,Disease ,Multiple modes ,Biology ,Multiple species ,medicine.disease ,Protein Aggregation, Pathological ,Biochemistry ,Protein Structure, Secondary ,Cell biology ,Superoxide dismutase ,Proteostasis ,Enzyme Stability ,Mutation ,medicine ,biology.protein ,Animals ,Humans ,Amyotrophic lateral sclerosis ,Molecular Biology - Abstract
ALS (amyotrophic lateral sclerosis) is a fatal neurodegenerative syndrome characterized by progressive paralysis and motor neuron death. Although the pathological mechanisms that cause ALS remain unclear, accumulating evidence supports that ALS is a protein misfolding disorder. Mutations in Cu,Zn-SOD1 (copper/zinc superoxide dismutase 1) are a common cause of familial ALS. They have complex effects on different forms of SOD1, but generally destabilize the protein and enhance various modes of misfolding and aggregation. In addition, there is some evidence that destabilized covalently modified wild-type SOD1 may be involved in disease. Among the multitude of misfolded/aggregated species observed for SOD1, multiple species may impair various cellular components at different disease stages. Newly developed antibodies that recognize different structural features of SOD1 represent a powerful tool for further unravelling the roles of different SOD1 structures in disease. Evidence for similar cellular targets of misfolded/aggregated proteins, loss of cellular proteostasis and cell–cell transmission of aggregates point to common pathological mechanisms between ALS and other misfolding diseases, such as Alzheimer's, Parkinson's and prion diseases, as well as serpinopathies. The recent progress in understanding the molecular basis for these devastating diseases provides numerous avenues for developing urgently needed therapeutics.
- Published
- 2014
18. Energetics of oligomeric protein folding and association
- Author
-
Jessica A.O. Rumfeldt, Johnathan J. Almey, Helen R. Broom, Elizabeth M. Meiering, Peter B. Stathopulos, Colleen M. Doyle, Kenrick A. Vassall, and Aron Broom
- Subjects
Protein Folding ,Chemistry ,Spectrum Analysis ,Protein subunit ,Energetics ,Protein design ,Biophysics ,Computational biology ,Calorimetry ,Biochemistry ,Oligomer ,Folding (chemistry) ,chemistry.chemical_compound ,Biopolymers ,Order (biology) ,Thermodynamics ,Protein folding ,Molecular Biology ,Function (biology) - Abstract
In nature, proteins most often exist as complexes, with many of these consisting of identical subunits. Understanding of the energetics governing the folding and misfolding of such homooligomeric proteins is central to understanding their function and misfunction, in disease or biotechnology. Much progress has been made in defining the mechanisms and thermodynamics of homooligomeric protein folding. In this review, we outline models as well as calorimetric and spectroscopic methods for characterizing oligomer folding, and describe extensive results obtained for diverse proteins, ranging from dimers to octamers and higher order aggregates. To our knowledge, this area has not been reviewed comprehensively in years, and the collective progress is impressive. The results provide evolutionary insights into the development of subunit interfaces, mechanisms of oligomer folding, and contributions of oligomerization to protein stability, function and regulation. Thermodynamic analyses have also proven valuable for understanding protein misfolding and aggregation mechanisms, suggesting new therapeutic avenues. Successful recent designs of novel, functional proteins demonstrate increased understanding of oligomer folding. Further rigorous analyses using multiple experimental and computational approaches are still required, however, to achieve consistent and accurate prediction of oligomer folding energetics. Modeling the energetics remains challenging but is a promising avenue for future advances.
- Published
- 2013
19. Probing the free energy landscapes of ALS disease mutants of SOD1 by NMR spectroscopy
- Author
-
Elizabeth M. Meiering, Lewis E. Kay, Ashok Sekhar, Jessica A.O. Rumfeldt, Ryan E. Sobering, Colleen M. Doyle, and Helen R. Broom
- Subjects
0301 basic medicine ,chemistry.chemical_classification ,Multidisciplinary ,biology ,Chemistry ,SOD1 ,Mutant ,Nuclear magnetic resonance spectroscopy ,medicine.disease ,3. Good health ,Folding (chemistry) ,Superoxide dismutase ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Enzyme ,PNAS Plus ,Biochemistry ,medicine ,Biophysics ,biology.protein ,Amyotrophic lateral sclerosis ,Conformational isomerism ,030217 neurology & neurosurgery - Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that, in some cases, has been linked with mutations to the antioxidant metalloenzyme superoxide dismutase (SOD1). Although the mature form of this enzyme is highly stable and resistant to aggregation, the most immature form, lacking metal and a stabilizing intrasubunit disulfide bond, apoSOD12SH, is dynamic and hypothesized to be a major cause of toxicity in vivo. Previous solution NMR studies of wild-type apoSOD12SH have shown that the ground state interconverts with a series of sparsely populated and transiently formed conformers, some of which have aberrant nonnative structures. Here, we study seven disease mutants of apoSOD12SH and characterize their free energy landscapes as a first step in understanding the initial stages of disease progression and, more generally, to evaluate the plasticity of low-lying protein conformational states. The mutations lead to little change in the structures and dynamics of the ground states of the mutant proteins. By contrast, the numbers of low-lying excited states that are accessible to each of the disease mutants can vary significantly, with additional conformers accessed in some cases. Our study suggests that the diversity of these structures can provide alternate interaction motifs for different mutants, establishing additional pathways for new and often aberrant intra- and intermolecular contacts. Further, it emphasizes the potential importance of conformationally excited states in directing both folding and misfolding processes.
- Published
- 2016
20. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria
- Author
-
Laurine Legroux, Helen R. Broom, Neil R. Cashman, Elizabeth M. Meiering, Sabrina Semmler, Laurie Destroismaisons, Christine Vande Velde, Sarah Pickles, and Nathalie Arbour
- Subjects
Male ,0301 basic medicine ,Protein Folding ,animal diseases ,Mutant ,SOD1 ,Mitochondrion ,Protein Aggregation, Pathological ,Antibodies ,Pathology and Forensic Medicine ,Superoxide dismutase ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Superoxide Dismutase-1 ,0302 clinical medicine ,JUNQ and IPOD ,Neuropil ,medicine ,Animals ,Humans ,Flow cytometry ,Proteostasis Deficiencies ,Amyotrophic lateral sclerosis ,biology ,Superoxide Dismutase ,Research ,Amyotrophic Lateral Sclerosis ,nutritional and metabolic diseases ,medicine.disease ,Molecular biology ,Recombinant Proteins ,Mitochondria ,nervous system diseases ,3. Good health ,Cell biology ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,Aggresome ,Spinal Cord ,nervous system ,Metals ,biology.protein ,Female ,Neurology (clinical) ,Rats, Transgenic ,030217 neurology & neurosurgery - Abstract
Approximately 20 % of familial Amyotrophic Lateral Sclerosis (ALS) is caused by mutations in superoxide dismutase (SOD1), which leads to misfolding of the SOD1 protein, resulting in a toxic gain of function. Several conformation-restricted antibodies have been generated that specifically recognize misfolded SOD1 protein, and have been used as therapeutics in pre-clinical models. Misfolded SOD1 selectively associates with spinal cord mitochondria in SOD1 rodent models. Using the SOD1G93A rat model, we find that SOD1 conformational specific antibodies AMF7-63 and DSE2-3H1 labeled a fibrillar network concentrated in the anterior horn; while A5C3, B8H10, C4F6 and D3H5 labeled motor neurons as well as puncta in the neuropil. There is a time-dependent accumulation of misfolded SOD1 at the surface of spinal cord mitochondria with AMF7-63-labeled mitochondria having increased volume in contrast to a mitochondrial subset labeled with B8H10. In spinal cord homogenates and isolated mitochondria, AMF7-63, DSE2-3H1 and B8H10 detect misfolded SOD1 aggregates. SOD1 that lacks its metal cofactors has an increased affinity for naïve mitochondria and misfolded SOD1 antibodies B8H10 and DSE2-3H1 readily detect demetalated mutant and wild-type SOD1. Together, these data suggest that multiple non-native species of misfolded SOD1 may exist, some of which are associated with mitochondrial damage. Conformational antibodies are invaluable tools to identify and characterize the variation in misfolded SOD1 species with regards to biochemical characteristics and toxicity. This information is highly relevant to the further development of these reagents as therapeutics. Electronic supplementary material The online version of this article (doi:10.1186/s40478-016-0313-8) contains supplementary material, which is available to authorized users.
- Published
- 2016
21. Whose Culture is it Anyway?-Lessons for Brexit
- Author
-
Turner, Chris, Trivedy, Chet, R Broom, and D Harmer
- Published
- 2016
- Full Text
- View/download PDF
22. The roof plate boundary is a bi-directional organiser of dorsal neural tube and choroid plexus development
- Author
-
Jonathan D. Gilthorpe, Thomas Butts, Emma R. Broom, Florent Campo-Paysaa, and Richard J. T. Wingate
- Subjects
Central Nervous System ,Neural Tube ,animal structures ,Green Fluorescent Proteins ,Chick Embryo ,Biology ,Fourth ventricle ,Cerebrospinal fluid ,Cytochrome P-450 Enzyme System ,Basic Helix-Loop-Helix Transcription Factors ,medicine ,Animals ,Prealbumin ,Molecular Biology ,Rhombic lip ,Research Articles ,Body Patterning ,Homeodomain Proteins ,Intracellular Signaling Peptides and Proteins ,Neural tube ,Membrane Proteins ,Anatomy ,Spinal cord ,Growth Differentiation Factors ,body regions ,Transplantation ,Neuroepithelial cell ,medicine.anatomical_structure ,Bone Morphogenetic Proteins ,Choroid Plexus ,embryonic structures ,Choroid plexus ,Signal Transduction ,Developmental Biology - Abstract
The roof plate is a signalling centre positioned at the dorsal midline of the central nervous system and generates dorsalising morphogenic signals along the length of the neuraxis. Within cranial ventricles, the roof plate gives rise to choroid plexus, which regulates the internal environment of the developing and adult brain and spinal cord via the secretion of cerebrospinal fluid. Using the fourth ventricle as our model, we show that the organiser properties of the roof plate are determined by its boundaries with the adjacent neuroepithelium. Through a combination of in ovo transplantation, co-culture and electroporation techniques in chick embryos between embryonic days 3 and 6, we demonstrate that organiser properties are maintained by interactions between the non-neural roof plate and the neural rhombic lip. At the molecular level, this interaction is mediated by Delta-Notch signalling and upregulation of the chick homologue of Hes1: chairy2. Gain- and loss-of-function approaches reveal that cdelta1 is both necessary and sufficient for organiser function. Our results also demonstrate that while chairy2 is specifically required for the maintenance of the organiser, its ectopic expression is not sufficient to recapitulate organiser properties. Expression of atonal1 in the rhombic lip adjacent at the roof plate boundary is acutely dependent on both boundary cell interactions and Delta-Notch signalling. Correspondingly, the roof plate boundary organiser also signals to the roof plate itself to specify the expression of early choroid plexus markers. Thus, the roof plate boundary organiser signals bi-directionally to acutely coordinate the development of adjacent neural and non-neural tissues.
- Published
- 2012
23. Combined Isothermal Titration and Differential Scanning Calorimetry Define Three-State Thermodynamics of fALS-Associated Mutant Apo SOD1 Dimers and an Increased Population of Folded Monomer
- Author
-
Kenrick A. Vassall, Ming Sze Tong, Helen R. Broom, Colleen M. Doyle, Elizabeth M. Meiering, Jessica A.O. Rumfeldt, and Julia Maeve Bonner
- Subjects
0301 basic medicine ,Protein Folding ,Dimer ,Population ,SOD1 ,Calorimetry ,Biochemistry ,Oligomer ,03 medical and health sciences ,chemistry.chemical_compound ,Differential scanning calorimetry ,Apoenzymes ,Superoxide Dismutase-1 ,Enzyme Stability ,Humans ,education ,education.field_of_study ,Superoxide Dismutase ,Amyotrophic Lateral Sclerosis ,Isothermal titration calorimetry ,Crystallography ,030104 developmental biology ,Monomer ,chemistry ,Mutation ,Thermodynamics ,Protein Multimerization - Abstract
Many proteins are naturally homooligomers, homodimers most frequently. The overall stability of oligomeric proteins may be described in terms of the stability of the constituent monomers and the stability of their association; together, these stabilities determine the populations of different monomer and associated species, which generally have different roles in the function or dysfunction of the protein. Here we show how a new combined calorimetry approach, using isothermal titration calorimetry to define monomer association energetics together with differential scanning calorimetry to measure total energetics of oligomer unfolding, can be used to analyze homodimeric unmetalated (apo) superoxide dismutase (SOD1) and determine the effects on the stability of structurally diverse mutations associated with amyotrophic lateral sclerosis (ALS). Despite being located throughout the protein, all mutations studied weaken the dimer interface, while concomitantly either decreasing or increasing the marginal stability of the monomer. Analysis of the populations of dimer, monomer, and unfolded monomer under physiological conditions of temperature, pH, and protein concentration shows that all mutations promote the formation of folded monomers. These findings may help rationalize the key roles proposed for monomer forms of SOD1 in neurotoxic aggregation in ALS, as well as roles for other forms of SOD1. Thus, the results obtained here provide a valuable approach for the quantitative analysis of homooligomeric protein stabilities, which can be used to elucidate the natural and aberrant roles of different forms of these proteins and to improve methods for predicting protein stabilities.
- Published
- 2015
24. Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways
- Author
-
Lewis E. Kay, Ashok Sekhar, Helen R. Broom, Colleen M. Doyle, Jessica A.O. Rumfeldt, Elizabeth M. Meiering, Guillaume Bouvignies, Department of Molecular Genetics [Toronto], University of Toronto, Canadian Institutes of Health Research (Instituts de recherche en sante du Canada), Canada Foundation for Innovation (Fondation canadienne pour l'innovation), Ontario Ministry of Economic Development and Innovation (Ministre Du Developpement Economique Et De L'innovation), and University of Toronto (UofT)
- Subjects
non-native oligomer ,QH301-705.5 ,Science ,SOD1 ,CPMG relaxation dispersion ,Protein aggregation ,General Biochemistry, Genetics and Molecular Biology ,protein aggregation ,Protein structure ,Native state ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Biology (General) ,human Cu, Zn superoxide dismutase ,General Immunology and Microbiology ,Chemistry ,General Neuroscience ,Energy landscape ,General Medicine ,transient conformation ,Folding (chemistry) ,Structural biology ,Biochemistry ,Biophysics ,Medicine ,Protein folding ,CEST - Abstract
International audience; Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease involving cytotoxic conformations of Cu, Zn superoxide dismutase (SOD1). A major challenge in understanding ALS disease pathology has been the identification and atomic-level characterization of these conformers. Here, we use a combination of NMR methods to detect four distinct sparsely populated and transiently formed thermally accessible conformers in equilibrium with the native state of immature SOD1 (apoSOD1(2SH)). Structural models of two of these establish that they possess features present in the mature dimeric protein. In contrast, the other two are non-native oligomers in which the native dimer interface and the electrostatic loop mediate the formation of aberrant intermolecular interactions. Our results show that apoSOD1(2SH) has a rugged free energy landscape that codes for distinct kinetic pathways leading to either maturation or non-native association and provide a starting point for a detailed atomic-level understanding of the mechanisms of SOD1 oligomerization.
- Published
- 2015
25. Author response: Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways
- Author
-
Ashok Sekhar, Elizabeth M. Meiering, Lewis E. Kay, Colleen M. Doyle, Jessica A.O. Rumfeldt, Helen R. Broom, and Guillaume Bouvignies
- Subjects
Folding (chemistry) ,Lead (geology) ,Chemistry ,Biophysics ,Thermal fluctuations - Published
- 2015
26. Retrospective epidemiological analysis of SARS-CoV-2 wastewater surveillance and case notifications data – New South Wales, Australia, 2020
- Author
-
H. S. Camphor, S. Nielsen, Z. Bradford-Hartke, K. Wall, and R. Broome
- Subjects
case notifications ,covid-19 ,public health response ,sars-cov-2 surveillance ,viral detection ,wastewater epidemiology ,Public aspects of medicine ,RA1-1270 - Abstract
This epidemiological study analysed SARS-CoV-2 wastewater surveillance and case notifications data to inform evidence-based public health action in NSW. We investigated measures of association between SARS-CoV-2 RNA fragments detected in wastewater samples (n = 100) and case notifications (n = 1,367, as rates per 100,000 population) within wastewater catchment areas (n = 6); and evaluated the performance of wastewater testing as a population-level diagnostic tool. Furthermore, we modelled SARS-CoV-2 RNA fragment detection in wastewater given the case notification rate using logistic regression. The odds of a viral detection in wastewater samples increased by a factor of 5.68 (95% CI: 1.51–32.1, P = 0.004) with rates of one or more notified cases within a catchment. The diagnostic specificity of wastewater viral detection results was 0.88 (95% CI: 0.69–0.97); the overall diagnostic sensitivity was 0.44 (95% CI: 0.33–0.56). The probability of a viral detection result in wastewater exceeded 50% (95% CI: 36–64%) once the case rate within a catchment exceeded 10.5. Observed results suggest that in a low prevalence setting, wastewater viral detections are a more reliable indicator of the presence of recent virus shedding cases in a catchment, than non-detect results are of the absence of cases in a catchment. HIGHLIGHTS Research was undertaken to investigate SARS-CoV-2 wastewater surveillance findings in relation to observed COVID-19 case notifications data in NSW, Australia.; In a low prevalence setting such as in NSW, wastewater viral detections, particularly in catchments with no recent case notifications should trigger prompt public health action to rule out low-level virus circulation or undetected community transmission.;
- Published
- 2022
- Full Text
- View/download PDF
27. Folding and Aggregation of Cu, Zn-Superoxide Dismutase
- Author
-
Peter B. Stathopulos, Kenrick A. Vassall, Elizabeth M. Meiering, Young-Mi Hwang, Jessica A.O. Rumfeldt, Heather A. Primmer, and Helen R. Broom
- Subjects
Genetics ,0303 health sciences ,Mutation ,Superoxide ,Mutant ,Cu-Zn Superoxide Dismutase ,SOD1 ,Biology ,medicine.disease_cause ,medicine.disease ,3. Good health ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,medicine ,Missense mutation ,Amyotrophic lateral sclerosis ,Gene ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
1.1 ALS and SOD1 In 1993, a genetic link was established between amyotrophic lateral sclerosis (ALS) and mutant forms of Cu,Zn superoxide dismutase (SOD1) (Deng et al. 1993; Rosen et al. 1993), an antioxidant enzyme that catalyzes the dismutation of the damaging free radical superoxide anion (O2-) to hydrogen peroxide (H2O2) and diatomic oxygen (O2) via cyclic reduction and oxidation of a protein-bound Cu ion (Valentine et al. 2005). Today, over 150, predominantly missense mutations have been identified at ~75 sites spread throughout the protein (http://alsod.iop.kcl.ac.uk/). SOD1 mutations are found in ~1520% of inherited or familial ALS (fALS) cases and in a small percentage of sporadic ALS (sALS) cases (Rosen et al. 1993; Kato et al. 2000; Liu et al. 2009; Forsberg et al. 2011). fALS accounts for ~10% of all ALS cases and so SOD1 mutations comprise ~1.5-2% of all ALS cases, but nevertheless represent a major known cause of the disease. The clinical symptoms of fALS and sALS are similar, yet fALS patients with SOD1 mutations have an earlier age of disease onset than sALS (by ~10 years) (Wijesekera and Leigh 2009). Furthermore, while the age of disease onset has not been identified as statistically different between different SOD1 mutations, disease duration for each mutation is often different, ranging from shorter (e.g. ~1 year for A4V, the most common mutation in North America) than the typical 3-5 years to longer (e.g. ~18 years for H46R) (Cudkowicz et al. 1997; Valentine et al. 2005; Wang et al. 2008). In humans and murine models of ALS, mutations in the gene encoding SOD1 are typically autosomal dominant and are associated with a toxic gain of function. Despite extensive research, the molecular basis for mutant SOD1 toxicity remains unclear (Valentine et al. 2005; Boillee et al. 2006; Ilieva et al. 2009). Extensive research has been conducted on SOD1-linked fALS, as understanding and treatment of this disease may be relevant to ALS in general. While ALS patients share many clinical symptoms, numerous genes have been linked to ALS, and there is evidence for differences in pathology related to both genetic and environmental factors; hence, ALS is a syndrome and not a single disease with unique pathology (Cozzolino et al. 2008).
- Published
- 2012
28. Further remains of the Sterkfonstein ape-man, Plesianthropus
- Author
-
R. Broom and J. T. Robinson
- Subjects
Male ,Multidisciplinary ,History ,Work (electrical) ,Law ,Humans - Abstract
At the beginning of April we restarted work at Sterkfontein in the search for more remains of Plesianthropus; and we were successful in getting remains of a number of individuals and a perfect skull of an elderly female, of which an announcement was made in Nature of May 17. Unfortunately, owing to a difference of opinion with the Historical Monuments Commission, further work was delayed for a month.
- Published
- 2010
29. Jaw of the male Sterkfontein ape-man
- Author
-
J. T. Robinson and R. Broom
- Subjects
Male ,Skull ,Multidisciplinary ,medicine.anatomical_structure ,stomatognathic system ,business.industry ,Mandible ,Medicine ,Animals ,Humans ,Anatomy ,business ,Condyle - Abstract
On June 24, we blasted out at Sterkfontein, at a spot only about 8 ft. away from where we discovered the old female skull of Plesianthropus, the almost perfect lower jaw of a large male. The left mandible is complete except for the loss of the condyle and a little part of the margin of the angle. The whole symphysial region appears to be complete, while the right ramus is much broken and crushed. All the teeth of the left side are present, though worn.
- Published
- 2010
30. Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples
- Author
-
Ingunn Holen, Susan J. Done, Orit Freedman, Eitan Amir, T. R. Cawthorn, R. Broom, Dong-Yu Wang, Mark Clemons, David Barth, and D. Gianfelice
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Pathology ,Neoplasm, Residual ,Biopsy ,Bone Neoplasms ,Breast Neoplasms ,Breast cancer ,Surgical oncology ,Bone Marrow ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,Osteopontin ,Prospective Studies ,RNA, Neoplasm ,Hematology ,biology ,medicine.diagnostic_test ,Gene Expression Profiling ,Bone metastasis ,General Medicine ,Middle Aged ,medicine.disease ,Neoplastic Cells, Circulating ,Gene expression profiling ,Gene Expression Regulation, Neoplastic ,medicine.anatomical_structure ,Oncology ,biology.protein ,Feasibility Studies ,Female ,Bone marrow - Abstract
The molecular mechanisms underlying the development of bone metastases in breast cancer remain unclear. Disseminated tumour cells (DTCs) in the bone marrow of breast cancer patients are commonly identified, even in early stage disease, but their potential to initiate metastases is not known. The mechanism whereby DTCs become overt metastatic tumour cells (MTCs) is therefore, an area of considerable interest. This study explored the analysable yield of genetic material from human biopsy samples in order to describe differences in gene expression between DTCs and bone MTCs. Thirteen breast cancer patients with bone metastases underwent a CT-guided bone metastasis biopsy and a bone marrow biopsy. Tumour cells were enriched and gene expression profiling was conducted to identify differentially expressed genes. The analysable yield of sufficient RNA for microarray analysis was 60% from bone metastasis biopsies and 80% from bone marrow biopsies. A signature of 133 candidate genes differentially expressed between DTCs and MTCs was identified. Several genes relevant to breast cancer metastasis to bone (osteopontin, CTGF, parathyroid hormone receptor, EGFR) were significantly overexpressed in MTCs as compared to DTCs. Biopsies of bone metastases and bone marrow rarely yield enough tissue for robust molecular biology studies using clinical samples. The findings obtained however are interesting and seem to overlap with the bone metastasis gene expression signature described in murine xenograft models. Larger biopsy specimens or improved RNA extraction techniques may improve analysable yield and feasibility of these techniques.
- Published
- 2009
31. P781: CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH LR-MDS REINITIATING ESAS FOLLOWING PREVIOUS ESA TREATMENT
- Author
-
G. Garcia-Manero, R. K. Matsuno, A. McBride, T. D. Brown, D. Idryo, R. Broome, A. Herriman, T. Johnson, K. Wilkinson, S. Walters, A. Schrag, C. Johanson, M. Izano, and S. Mukherjee
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
32. Folding and Aggregation of Cu, Zn-Superoxide Dismutase
- Author
-
Helen R. Broom, Heather A. Primmer, Jessica A.O. Rumfeldt, Peter B. Stathopulos, Kenrick A. Vassall, Young-Mi Hwang, Elizabeth M. Meiering, Helen R. Broom, Heather A. Primmer, Jessica A.O. Rumfeldt, Peter B. Stathopulos, Kenrick A. Vassall, Young-Mi Hwang, and Elizabeth M. Meiering
- Published
- 2012
- Full Text
- View/download PDF
33. Novel Two-Dimensional Perovskites
- Author
-
J. G. Bednorz, K. H. Wachtmann, R. Broom, and D. Ariosa
- Published
- 1997
34. Some new Types of Mammal-like Reptiles.
- Author
-
D.Sc., R. Broom., primary
- Published
- 2009
- Full Text
- View/download PDF
35. Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
- Author
-
Susan J. Done, Mark Clemons, Harriette J. Kahn, Eitan Amir, David Barth, R. Broom, D. Gianfelice, W.S. Ooi, and Orit Freedman
- Subjects
Oncology ,medicine.medical_specialty ,Pathology ,Standard of care ,Bone disease ,medicine.diagnostic_test ,business.industry ,medicine.disease ,medicine.anatomical_structure ,Breast cancer ,Hormone receptor ,Surgical oncology ,Internal medicine ,Biopsy ,Poster Presentation ,medicine ,Bone marrow ,Primary breast cancer ,business - Published
- 2009
36. Phase I/II feasibility trial of adjuvant dose-dense (DD) docetaxel/epirubicin/cyclophosphamide (TEC) in stage II/III breast cancer
- Author
-
Hyman B. Muss, Abigail Crocker, Takamaru Ashikaga, R. Broom, Susan Burdette-Radoux, Marie E. Wood, and J. J. Olin
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Taxane ,Anthracycline ,Cyclophosphamide ,business.industry ,TEC ,medicine.medical_treatment ,medicine.disease ,Surgery ,Breast cancer ,Internal medicine ,Adjuvant therapy ,Medicine ,Stage (cooking) ,business ,Adjuvant ,medicine.drug - Abstract
813 Background: Strategies for improving outcome of adjuvant therapy for early stage breast cancer (BC) include escalating anthracycline dose, adding a taxane, and DD scheduling. In this phase I/II...
- Published
- 2005
37. Characteristics of in-line Josephson tunneling gates
- Author
-
R. Broom and S. Basavaiah
- Subjects
Condensed Matter::Quantum Gases ,Physics ,Josephson effect ,Condensed matter physics ,Electronic, Optical and Magnetic Materials ,law.invention ,Pi Josephson junction ,SQUID ,law ,Condensed Matter::Superconductivity ,Line (geometry) ,Superconducting tunnel junction ,Boundary value problem ,Electrical and Electronic Engineering ,Penetration depth ,Quantum tunnelling - Abstract
Characteristics of in-line Josephson gates have been computed, using numerical techniques, for a number of differing junction length to Josephson penetration depth ratios. These are verified by systematic experimental results, where the agreement between theory and experiment was found to be good.
- Published
- 1975
38. OBSERVATIONS ON SOME SPECIMENS OF SOUTH AFRICAN FOSSIL REPTILES PRESERVED IN THE BRITISH MUSEUM
- Author
-
R. Broom
- Subjects
Paleontology ,Geography ,General Earth and Planetary Sciences ,General Medicine ,General Agricultural and Biological Sciences ,Archaeology ,General Environmental Science - Abstract
n/a
- Published
- 1910
39. ON THE STRUCTURE AND AFFINITIES OF THE ENDOTHIODONT REPTILES
- Author
-
R. Broom and B.Sc.
- Subjects
Stereochemistry ,Chemistry ,General Earth and Planetary Sciences ,General Medicine ,General Agricultural and Biological Sciences ,Affinities ,General Environmental Science - Published
- 1904
40. A new mandible of the ape-man Plesianthropus transvaalensis
- Author
-
R. Broom and J. T. Robinson
- Subjects
Male ,Orthodontics ,Anthropology ,Mandible ,Humans ,Anatomy ,Biology - Published
- 1949
41. On some New South African Permian Reptiles*
- Author
-
R. Broom
- Subjects
Paleontology ,Geography ,Permian ,General Medicine - Published
- 1911
42. 32. On the Pygocephalus ‐like Crustacean of the South African Dwyka
- Author
-
R. Broom
- Subjects
Zoology ,General Medicine ,Biology ,biology.organism_classification ,Crustacean - Published
- 1931
43. OBSERVATIONS ON THE STRUCTURE OFMESOSAURUS
- Author
-
R. Broom and B.Sc.
- Subjects
Materials science ,Chemical physics ,Structure (category theory) ,General Earth and Planetary Sciences ,General Medicine ,General Agricultural and Biological Sciences ,General Environmental Science - Published
- 1904
44. On the Structure of the Reptilian Tarsus
- Author
-
R. Broom
- Subjects
medicine.anatomical_structure ,Tarsus (skeleton) ,medicine ,General Medicine ,Anatomy ,Biology - Published
- 1921
45. On the ossification of the vertebrae in the wombat and other marsupials
- Author
-
R Broom
- Subjects
Wombat ,biology ,Ossification ,biology.animal ,medicine ,Anatomy ,medicine.symptom ,General Agricultural and Biological Sciences ,General Environmental Science - Published
- 1901
46. 21. On a new Type of Primitive Fossil Reptile from the Upper Permian of South Africa
- Author
-
R. Broom
- Subjects
Paleontology ,Type (biology) ,Permian ,Ecology ,General Medicine ,Biology - Published
- 1938
47. ON THE AFFINITIES OFTRITYLODON
- Author
-
R. Broom
- Subjects
Tritylodon ,Geography ,biology ,Stereochemistry ,General Earth and Planetary Sciences ,General Medicine ,General Agricultural and Biological Sciences ,biology.organism_classification ,Affinities ,General Environmental Science - Published
- 1905
48. I. Croonian Lecture : On the origin of mammals
- Author
-
R. Broom
- Subjects
Character (mathematics) ,Personal interest ,Evolutionary biology ,Zoology ,Evolution of mammals ,Biology ,Possession (law) ,Relation (history of concept) ,Simple (philosophy) - Abstract
Since in the last 50 years the belief in the descent of all higher forms of life from earlier types has become universal, the desire to discover the origins of things has grown strong and there is probably no group in whose origin we are more interested than that to which we ourselves belong. The problem is fascinating not only because of our personal interest, but perhaps nearly as much on account of its difficulty. The living mammals differ so very markedly from all other living vertebrates that there is no group to which they seem nearly related, and none which is manifestly ancestral to them. With many marvellous specialisations and many peculiar degenerations, they retain a host of primitive characters. In some features they resemble the lizards; in others more strikingly do they agree with Sphenodon . In the possession of a secondary palate and in some other characters they seem to have some Crocodilian affinity; in developing with a primitive streak and in one or two other points they agree with the birds. In the simple character of the bones of the skull, in the relation of certain blood-vessels, and in certain points in the ontogeny the affinities seem nearer to the amphibians than to the living reptiles; and a few characters even seem to suggest an origin directly from some group of fishes. For the solution of the problem we seem to be restricted to three lines of research—Comparative Anatomy, Embryology and Palæontology—and unfortunately all three are subject to serious limitations.
- Published
- 1915
49. Second report of the Committee on the Nomenclature of the Cranial Elements in the Permian Tetrapoda
- Author
-
Samuel W. Williston, D. M. S. Watson, R. Broom, and William K. Gregory
- Subjects
Permian ,Watson ,Law ,Unanimity ,Geology ,Object (philosophy) ,Nomenclature - Abstract
Introduction On June 29,1915, Prof. H. F. Osborn requested Prof. S. W. Williston to act as chairman of a committee consisting of Messrs. S. W. Williston, E. C. Case, R. L. Moodie, D. M. S. Watson, and W. K. Gregory, the object of the committee being to consider and revise the names of the cranial elements of the earliest Tetrapoda. Dr. R. Broom was later appointed by the chairman. The committee has never been able to assemble and discuss the matter together, but each member has expressed his own views in correspondence with the Secretary and has had opportunity to consider the views of the other members of the committee. The first report of the committee was made by the Secretary at the Washington meeting of the Paleontological Society in December, 1915. It is not yet possible to secure entire unanimity in the committee either as to the principles which must . . .
- Published
- 1917
50. Simple analysis of a diode laser having two orthogonal Fabry-Perot cavities
- Author
-
R. Broom
- Subjects
Physics ,business.industry ,Physics::Optics ,Response time ,Rate equation ,Injection seeder ,Condensed Matter Physics ,Laser ,Atomic and Molecular Physics, and Optics ,law.invention ,Optics ,Laser diode rate equations ,law ,Electrical and Electronic Engineering ,Atomic physics ,business ,Tunable laser ,Fabry–Pérot interferometer ,Diode - Abstract
Simple rate equations have been used to analyze the steady-state behavior of a double-cavity diode laser with two separately driven active regions, one of which is shared by both cavities. It is shown that the output from one cavity depends with an inverse linear relationship on the output of the other, in agreement with the experimental results of Kosonocky, Cornely, and Marlowe. The stability of the steady-state solutions has been studied by a perturbation method, yielding a value for the response time of 0.2 ns. It is found that unstable situations exist for certain values of some of the parameters, indicating the possibility of an oscillatory output. A similar method of analysis has been used to obtain the response time of a normal single-cavity laser. For abrupt changes in the drive current when the laser is already emitting, the calculated response time is in good agreement with the experimental values obtained by Basov et al.
- Published
- 1969
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.